Circadian rhythms of frequency domain measures of heart rate variability in healthy subjects and patients with coronary artery disease. Effects of arousal and upright …

HV Huikuri, MJ Niemelä, S Ojala, A Rantala… - Circulation, 1994 - Am Heart Assoc
BACKGROUND Altered neural regulation of the cardiovascular system may be an important
factor for various manifestations of ischemic heart disease. This research was designed to …

Frequency domain measures of heart rate variability before the onset of nonsustained and sustained ventricular tachycardia in patients with coronary artery disease.

HV Huikuri, JO Valkama, KE Airaksinen, T Seppänen… - Circulation, 1993 - Am Heart Assoc
BACKGROUND Low heart rate variability (HRV) is associated with an increased risk of
arrhythmic death and ventricular tachycardia (VT). The purpose of this study was to examine …

Impaired vagal heart rate control in coronary artery disease.

KE Airaksinen, MJ Ikäheimo, MK Linnaluoto… - Heart, 1987 - heart.bmj.com
Heart rate variation in deep breathing, a sensitive non-invasive measure of cardiac
parasympathetic activity, was measured in 63 patients with coronary artery disease, in 22 …

Meta-analysis of the outcome after postcardiotomy venoarterial extracorporeal membrane oxygenation in adult patients

F Biancari, A Perrotti, M Dalén, M Guerrieri… - Journal of cardiothoracic …, 2018 - Elsevier
Objective This study was planned to pool existing data on outcome and to evaluate the
efficacy of postcardiotomy venoarterial extracorporeal membrane oxygenation (VA-ECMO) …

The optimal management of patients on oral anticoagulation undergoing coronary artery stenting

A Rubboli, DP Faxon, JKE Airaksinen… - Thrombosis and …, 2014 - thieme-connect.com
Even 10 years after the first appearance in the literature of articles reporting on the
management of patients on oral anticoagulation (OAC) undergoing percutaneous coronary …

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of …

HV Huikuri, K Kervinen, M Niemelä… - European heart …, 2008 - academic.oup.com
Aims To assess the efficacy and safety of bone marrow cell (BMC) therapy after thrombolytic
therapy of an acute ST-elevation myocardial infarction (STEMI). Methods and results …

[PDF][PDF] Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trial

PP Karjalainen, A Ylitalo, M Niemelä, K Kervinen… - …, 2008 - academia.edu
Aims: The aim of this study was to evaluate the effectiveness of titanium-nitride-oxide
(TITANOX)-coated stent and paclitaxel-eluting stent (PES) in patients presenting with acute …

Optimal timing for cardioversion in patients with atrial fibrillation

T Hellman, T Kiviniemi, I Nuotio, F Biancari… - Clinical …, 2018 - Wiley Online Library
Background Electrical cardioversion (CV) is essential in rhythm management of atrial
fibrillation (AF). However, optimal timing of CV remains unknown. Hypothesis Timing of CV …

Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A

R Tertti, S Wittfooth, P Porela, KE Airaksinen… - Clinical …, 2009 - academic.oup.com
Background: Pregnancy-associated plasma protein A (PAPP-A) has been suggested as a
useful diagnostic and prognostic marker in acute coronary syndromes. Because low …

Heart rate dynamics during accentuated sympathovagal interaction

MP Tulppo, TH Makikallio… - American Journal …, 1998 - journals.physiology.org
Concomitant sympathetic and vagal activation can occur in various physiological conditions,
but there is limited information on heart rate (HR) behavior during the accentuated …